SCHEMBL24309498

SCHEMBL24309498

CCc1c(Oc2ccc(N3CCNCC3)cc2)nc(NSc2cnn(C)c2)nc1-c1c(C)c(C)cc(C)c1C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 4/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CCND2 P30279 1/20 0.32
▸ CCND3 P30281 1/20 0.32
▸ CCNA1 P78396 1/20 0.32
▸ CCNB3 Q8WWL7 1/20 0.32
▸ LCK P06239 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ BTK Q06187 1/20 0.32
▸ TNK2 Q07912 1/20 0.32
▸ LTA4H P09960 4/20 0.31
▸ BMPR1B O00238 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310026 0.92 ACVR1 (0.32) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL24310025 0.88 TNK2 (0.35) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL24310019 0.85 LTA4H (0.39) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL29567256 0.84 NOD2 (0.36) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL24309496 0.84 NOD2 (0.36) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL24310046 0.83 LTA4H (0.34) ACVR1CDK1CDK4CCNB1CCNA2
SCHEMBL24309744 0.81 LTA4H (0.38) ACVR1CCNA2CCND1CDK2CCND3
SCHEMBL24310033 0.81 LTA4H (0.32) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL24309902 0.78 IGF1R (0.37) ACVR1LCKJAK3BTKTNK2
SCHEMBL29566401 0.76 NOD2 (0.36) ACVR1LCKJAK3BTKTNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback